Bird flu scare: All UP zoos, lion safari shut for visitors till May 27
Gorakhpur, Lucknow and Kanpur zoos were already shut till May 20 in wake of bird flu deaths but the closure has now been extended. 'The closure of zoos is precautionary, and to ensure all protocols for H5 avian influenza are followed for safety of birds and animals,' said Saxena.
The closure of the Shaheed Ashfaq Ullah Khan Zoological Park in Gorakhpur may be extended further said officials. A public notice regarding the indefinite closure has been posted at the zoo entrance.
So far, deaths of Tiger 'Keshri', aged over seven years, on March 30, followed by that of a leopard on April 7, Tigress 'Shakti' on May 8, Lion 'Pataudi' on May 15, and a peacock have been confirmed due to bird flu in Gorakhpur and Kanpur zoos.
A team formed by the Central Zoo Authority (CZA) is on an inspection at Gorakhpur zoo, where the first death was reported. The team includes officials from the animal husbandry department, Bhopal-based National Institute of High Security Animal Diseases (NIHSAD) and officials from the Indian Veterinary Research Institute (IVRI), Bareilly. On the second day of their investigation, the panel collected random samples from key animals, including a Barbary Lion and two other big cats.
Besides, more than 50 environmental samples were collected, including bird droppings, surface swabs, and drinking water sources.
Gorakhpur zoo director Vikas Yadav stated that the extended closure is a precautionary measure to prevent any potential outbreak.
Meanwhile concerns rose following the discovery of dead crows within the zoo premises. As of Monday evening, the total number of crow deaths on-site rose to nine. Veterinary staff sent the latest samples to the Indian Veterinary Research Institute (IVRI), Bareilly, for further analysis.
Meanwhile, Covid protocols have been implemented in one-kilometre radius around the Kanpur zoo in wake of the avian influenza scare. The action follows the deaths of a lion and a peacock within the past week, prompting concern among local authorities and residents.
Additional CMO Dr Rajeshwar Tiwari said Covid protocols have been enforced as avian influenza can be transmitted to humans. 'People must wash their hands regularly, wear face masks, and maintain physical distance,' he said, adding a medical team will monitor the area, examine residents, collect samples where required, and provide medicines as needed.
A significant population resides around the zoo. One of the housing projects developed by the Kanpur Development Authority is situated adjacent the zoo's hospital and incineration zone. Many residents living close to the facility have expressed concern and kept their windows shut as a safety measure.
Central Zoo Authority (CZA) officials are expected to carry out an inspection of the zoo on Wednesday and likely to recommend additional steps to prevent spread of infection.
According to regional forest officer Naved Ikram, no animal deaths were reported on Tuesday. He noted that blood and swab samples from 11 animals have been sent to a laboratory in Bhopal, and the results are expected by Wednesday morning. Samples from zoo staff and water collected from various parts of the zoo have also been submitted for testing. 'At present, the situation appears to be under control,' Ikram said.
Two tigresses, Aadya and Pushpa, reportedly consumed only half their usual meal on Tuesday, and their condition is being watched closely by veterinary staff.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
21 minutes ago
- The Hindu
Cancer hospital celebrates first anniversary of BMT unit
Homi Bhabha Cancer Hospital and Research Centre (HBCHRC), Tata Memorial Centre, Visakhapatnam, celebrated the first anniversary of its Bone Marrow Transplant (BMT) Unit on Tuesday. The event brought together doctors, staff, patients, and families to commemorate the unit's milestones. Since its inception, the centre has completed 18 transplants—13 autologous and 5 allogenic—and recently introduced a TBI-based conditioning regimen, available in only a few centres in Andhra Pradesh. HBCHRC Director Umesh Mahantshetty said the BMT Unit has been a 'symbol of resilience and teamwork,' particularly in making advanced treatments accessible to underprivileged patients. He acknowledged the support of the Ministry of Health and Family Welfare, TMC patient welfare funds, Indian Cancer Society, and local philanthropists. Future plans include introducing haploidentical transplantations and CAR-T cell therapy.
The Hindu
3 hours ago
- The Hindu
NHRC directs Telangana Education dept. for report in student's death
The National Human Rights Commission (NHRC) on Tuesday directed Secretary (Education) Yogitha Rana for a comprehensive report concerning the death of a 16-year-old girl in Government Ashram High School for Girls in Wankidi, Komaram Bheem Asifabad district, last year. The girl along with two other students were admitted to Nizam's Institute of Medical Sciences with severe gastroenteritis symptoms, after they reportedly consumed food from their school. While the latter two were discharged, the girl in critical condition died while being treated on November 25. The NHRC, responding to Hyderabad-based advocate Rama Rao Immaneni's petition, opened an investigation and directed Ms. Yogitha Rana to submit the report within four weeks.
The Hindu
3 hours ago
- The Hindu
Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO
For Indian pharma industry, there is bound to be disruption initially in the event of the U.S. imposing tariff but over time the drugmakers will look to pass on some of the impact to the customers, a top executive of a well known company said. With the U.S. market accounting for a significant part of the portfolio, the industry, however, has to brace for it, Natco Pharma vice-chairman and CEO Rajeev Nannapaneni responded to queries on the impact, in the event of the levy, during an earnings call recently. who had earlier this year highlighted how it is important for drugmakers to get a front-end manufacturing foothold in the U.S. as a counter measure, said the company needs to readjust strategy based on the policy. U.S. is still the most important pharmaceutical market in the world, particularly for some products that account for around two-third of the business. 'You can't ignore 60-70% of the business and run your business,' he said, while pointing out at Natco Pharma's ongoing efforts to build a business outside U.S. The Hyderabad-based firm had recently announced it will be acquiring 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). Over time, the investment will contribute to a 'significant part of our base earnings'... I would believe South Africa will easily be about 15-25% of the base earnings. So we are diversifying away from the U.S. as well. It's not that we are not. But again, you can't ignore U.S. at the same time. So you have to play both the cards,' he said. To another query related on impact of tariffs, sought to explain how it would not be easy to pass through immediately considering the contracts and pricing. But, in the long run, 'we would like to pass it on to our customers because the margins that we work on most of our products are very low. So, there will be some little bit of disruption initially, but I think eventually we will figure out after a quarter.'
